131 related articles for article (PubMed ID: 14588150)
1. Activation of tyrosine kinases by reactive oxygen species in vascular smooth muscle cells: significance and involvement of EGF receptor transactivation by angiotensin II.
Frank GD; Eguchi S
Antioxid Redox Signal; 2003 Dec; 5(6):771-80. PubMed ID: 14588150
[TBL] [Abstract][Full Text] [Related]
2. Reactive oxygen species mediate Endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells.
Daou GB; Srivastava AK
Free Radic Biol Med; 2004 Jul; 37(2):208-15. PubMed ID: 15203192
[TBL] [Abstract][Full Text] [Related]
3. Distinct mechanisms of receptor and nonreceptor tyrosine kinase activation by reactive oxygen species in vascular smooth muscle cells: role of metalloprotease and protein kinase C-delta.
Frank GD; Mifune M; Inagami T; Ohba M; Sasaki T; Higashiyama S; Dempsey PJ; Eguchi S
Mol Cell Biol; 2003 Mar; 23(5):1581-9. PubMed ID: 12588978
[TBL] [Abstract][Full Text] [Related]
4. cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.
Ushio-Fukai M; Zuo L; Ikeda S; Tojo T; Patrushev NA; Alexander RW
Circ Res; 2005 Oct; 97(8):829-36. PubMed ID: 16151024
[TBL] [Abstract][Full Text] [Related]
5. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL
Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species.
Meng D; Shi X; Jiang BH; Fang J
Free Radic Biol Med; 2007 Jun; 42(11):1651-60. PubMed ID: 17462533
[TBL] [Abstract][Full Text] [Related]
7. Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR.
Sandoval YH; Li Y; Anand-Srivastava MB
Cell Signal; 2011 Nov; 23(11):1716-26. PubMed ID: 21712088
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-phosphate transactivates the platelet-derived growth factor beta receptor and epidermal growth factor receptor in vascular smooth muscle cells.
Tanimoto T; Lungu AO; Berk BC
Circ Res; 2004 Apr; 94(8):1050-8. PubMed ID: 15044318
[TBL] [Abstract][Full Text] [Related]
9. Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src.
Saito S; Frank GD; Mifune M; Ohba M; Utsunomiya H; Motley ED; Inagami T; Eguchi S
J Biol Chem; 2002 Nov; 277(47):44695-700. PubMed ID: 12226102
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine inhibits angiotensin ii-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor.
Frank GD; Eguchi S; Inagami T; Motley ED
Biochem Biophys Res Commun; 2001 Feb; 280(4):1116-9. PubMed ID: 11162642
[TBL] [Abstract][Full Text] [Related]
11. PYK2/CAKbeta represents a redox-sensitive tyrosine kinase in vascular smooth muscle cells.
Frank GD; Motley ED; Inagami T; Eguchi S
Biochem Biophys Res Commun; 2000 Apr; 270(3):761-5. PubMed ID: 10772898
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of hypoxia-inducible factor-1 through receptor tyrosine kinase transactivation in vascular smooth muscle cells.
Lauzier MC; Pagé EL; Michaud MD; Richard DE
Endocrinology; 2007 Aug; 148(8):4023-31. PubMed ID: 17510240
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II promotes smooth muscle cell proliferation and migration through release of heparin-binding epidermal growth factor and activation of EGF-receptor pathway.
Yang X; Zhu MJ; Sreejayan N; Ren J; Du M
Mol Cells; 2005 Oct; 20(2):263-70. PubMed ID: 16267402
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells.
Ushio-Fukai M; Griendling KK; Becker PL; Hilenski L; Halleran S; Alexander RW
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):489-95. PubMed ID: 11304462
[TBL] [Abstract][Full Text] [Related]
15. Activation of insulin-like growth factor type-1 receptor is required for H2O2-induced PKB phosphorylation in vascular smooth muscle cells.
Azar ZM; Mehdi MZ; Srivastava AK
Can J Physiol Pharmacol; 2006 Jul; 84(7):777-86. PubMed ID: 16998541
[TBL] [Abstract][Full Text] [Related]
16. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
17. Urotensin II-induced endothelin-1 expression and cell proliferation via epidermal growth factor receptor transactivation in rat aortic smooth muscle cells.
Tsai CS; Loh SH; Liu JC; Lin JW; Chen YL; Chen CH; Cheng TH
Atherosclerosis; 2009 Sep; 206(1):86-94. PubMed ID: 19269634
[TBL] [Abstract][Full Text] [Related]
18. Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II.
Frank GD; Eguchi S; Yamakawa T; Tanaka S; Inagami T; Motley ED
Endocrinology; 2000 Sep; 141(9):3120-6. PubMed ID: 10965882
[TBL] [Abstract][Full Text] [Related]
19. Transactivation of the insulin-like growth factor-I receptor by angiotensin II mediates downstream signaling from the angiotensin II type 1 receptor to phosphatidylinositol 3-kinase.
Zahradka P; Litchie B; Storie B; Helwer G
Endocrinology; 2004 Jun; 145(6):2978-87. PubMed ID: 14976148
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature.
Nakashima H; Suzuki H; Ohtsu H; Chao JY; Utsunomiya H; Frank GD; Eguchi S
Curr Vasc Pharmacol; 2006 Jan; 4(1):67-78. PubMed ID: 16472178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
